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The development of aesthetically unattractive white spots is a concern for patients 
undergoing fixed orthodontic treatment. Due to poor oral hygiene during treatment, 
accumulation of plaque around orthodontic brackets causes bacterial fermentation 
reactions producing acids that dissolve the mineral enamel. Such dissolution results in 
white spot formation, an early sign of dental caries. In principal, to inhibit the appearance 
of these spots during treatment, fluoridated elastomeric o-rings might be employed. Once 
placed around brackets, these o-rings should release fluoride therapeutically for at least 
 ix
30 days, after which the orthodontist may replace them. At the present time, such 
fluoride-releasing o-rings are not available. 
In this study, model materials for fluoride-releasing elastomeric o-rings were 
developed. These materials were fluoride-impregnated poly(ethylene-co-vinyl acetate) 
(PEVA) films. In vitro release studies of these films were conducted, assessing their 
capacity to deliver fluoride within therapeutic range (1.2 ≤ µg F/ring/day ≤ 51.4) for 30-
45 days. Optimal sample and experimental parameters, including (1) fluoride loading in 
the film (wt% F), (2) overcoat thickness, and (3) temperature that provided therapeutic 
release, were determined. At 37°C, favorable release was observed for the following: (1) 
films with overcoat thickness of 0.14 mm and fluoride loadings of 3.9 wt% and 5.7 wt% 
and (2) films with overcoat thickness of 0.27 mm and fluoride loading of 5.7 wt%. These 
results are important in providing fundamental guidance for the development of o-rings 
that combat white spot formation among orthodontic patients. 
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CHAPTER 1 Overview 
 
 
1.1  White Spot Lesions (WSLs) 
In patients undergoing fixed orthodontic treatment, the development of white spot 
lesions (WSLs) is a concern.1-3 A clinical trial examined WSL incidence related to brace 
treatment and found that 50% of patients were affected.1 The process of WSL 
development is rapid - the initial formation may appear within only four weeks of 
treatment.3 
The occurrence of WSLs is an early stage of the medical condition, dental caries. 
WSLs are opaque areas of demineralized enamel (Figure 1). They occur due to plaque 
accumulation on enamel areas adjacent to the orthodontic brackets, areas from which 
plaque removal by conventional cleaning methods (e.g. brushing) is problematic. Plaque 
 
Figure 1. Image of teeth after removal of orthodontic 
appliances. On circled areas, WSLs can be 
distinguished from normal enamel surfaces. 
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bacteria undergo fermentation reactions with sugars to produce acids, lowering the oral 
pH and favoring the dissolution of the enamel mineral - hence WSLs form. Topical 
fluoride agents, such as toothpaste and mouth rinses, can inhibit demineralization by 
promoting remineralization. The fluoride ions [F־] contained in topical technologies 
attract calcium ions from the saliva, resulting in partial calcification of demineralized 
enamel areas, i.e. remineralization occurs. 
The appearance of WSLs presents an aesthetic problem to patients. After bracket 
removal at the end of treatment, WSLs may start to regress due to remineralization under 
fluoride therapy. However, these unsightly white spots may still remain visible even 5 
years following treatment.4 To combat WSL formation during brace treatment, 
efficacious fluoride treatments are needed. 
 
1.2  Factors Affecting the Efficacy of Fluoride Technologies 
Various fluoride technologies sought to mitigate demineralization by providing a 
local source of fluoride. These technologies may be classified into three groups:  (1) 
topical fluorides - e.g. toothpastes, mouth rinses, gels, and varnishes; (2) fluoride-
releasing bonding materials - e.g. composite resins and glass ionomer cements (GICs); 
and (3) fluoridated elastomerics - e.g. Fluor-I-Ties® and Fluor-I-Chain®. The therapeutic 
effectiveness of these fluoride agents can be assessed by considering one or both of the 
following two factors: (1) patient compliance and/or (2) kinetics of fluoride release. 
Studies suggest that topical fluoride regimens (toothpaste, mouth rinses, gels, and 
varnishes) may be therapeutically beneficial.3, 5-10 For example, daily mouth rinsing with 
 3
0.05% sodium fluoride is recommended.11 However, quantifying the efficacy of these 
topical fluorides is problematic due to unpredictable patient compliance.7, 8, 12 A clinical 
study showed that only 13% of patients showed compliance in daily sodium fluoride 
mouth rinsing.7 
In contrast, fluoride-releasing bonding materials and elastomerics do not require 
patient compliance. The therapeutic value of such technologies can be understood by 
considering the kinetics of fluoride release. In this regard, it is important to define, in a 
qualitative manner, release kinetics; two important cases of which ought to be noted 
(Figure 2). The first situation involves rapid release in a short period of time - i.e. “burst 
effect” is observed – and, after which, there is subsidence of release (Figure 2A). Such 
rapid release typically provides over-release at early times and non-therapeutic release 
thereafter. In contrast, the ideal profile is one that shows constant fluoride release with 
time (Figure 2B). 
Fluoride-releasing bonding materials and elastomerics should deliver fluoride at 
therapeutic rates for extended periods of time. The former technologies, particularly 
composite resins and glass ionomer cements (GICs), may be therapeutic, but only short-
term.13-16 According to studies, burst release is observed for orthodontic adhesives.17, 18 
Bonding materials may provide therapeutic protection only during the burst release 
period (represented in Figure 2A). 
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In hopes of providing long-term therapeutic release, fluoride impregnated 
elastomerics, namely, Fluor-I-Ties® and Fluor-I-Chain®, were developed (by Ortho Arch 
Company, Illinois). The former and latter were elastomeric modules (rings) and chains 
respectively (Figure 3). There were two advantages to using such fluoride-releasing 
elastomerics. First, patient compliance was not necessary for therapeutic effect. Second, 
the oral fluoride source was easily regenerated, as the patient’s elastomerics were simply 
replaced at each orthodontic visit. For both Fluor-I-Ties® and Fluor-I-Chain®, studies 
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Figure 2. Model release profiles. (A) “Burst effect” is depicted on cumulative and daily 
release graphs (left and right, respectively). (B) Constant release is depicted on cumulative 
and daily release graphs (left and right, respectively). 
 5
suggest that the incidence of enamel 
decalcification may be reduced, but not 
eliminated.19, 20 A clinical trial compared the 
enamel decalcification rate of two groups of 
patients - one group received treatment with 
Fluor-I-Chain®, while the other received non-
fluoridated elastomers.19 The incidence of enamel decalcification for the former and latter 
groups were 63% (31 out of 49 patients) and 73% (33 out of 45 patients) respectively. It 
is important to note that, although the incidence of decalcification decreased with Fluor-I-
Chain®, the incidence is still high, i.e. 63% of patients still experienced decalcification 
with Fluor-I-Chain®. Moreover, the incidence rates of the experimental and control 
groups (63% and 73%) may not be statistically different. Benson et al.11 stated that “there 
was no statistically significant difference in the odds ratio between the fluoridated elastics 
group (31 patients out of 49 with WSL) compared with the non-fluoridated elastics group 
(33 out of 45 with WSL), Peto OR 0.63 (95% CI 0.27-1.50).” These reviewers analyzed 
the statistical methods employed by the clinical trial and concluded that “the study was 
judged to be a high risk of bias,” mainly due to two reasons: (1) the method of allocation 
was alternate; and (2) no method of allocation blinding was discussed – “one individual 
carried out the final recording and undertook an estimation of error; however, the 
assessor was one of the three clinicians who had treated the patients.”11 
Furthermore, in vivo and in vitro studies demonstrated that both Fluor-I-Ties® and 
Fluor-I-Chain® were not consistent, low-dose fluoride-releasing systems.21-23 An in vivo 
 
 
 
Figure 3. Elastomeric: (A) Modules. 
(B) Chain.
A
B 
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study with Fluor-I-Ties® reported that 90% of the total fluoride content was released in 
one week.22 An in vitro study with Fluor-I-Chain® showed that, of the total fluoride 
content, 50% is released in one day and 90% in one week.21 The burst release of fluoride 
from these fluoridated elastomers may therefore be represented by the model given in 
Figure 2A. 
In summary, quantifying the efficacy of the various fluoride delivery methods is 
problematic as they exhibit one or both of the following two characteristics: (1) they 
require patient compliance in order to gain therapeutic effect, as in some topical fluorides 
(e.g. mouth rinses), and/or (2) they exhibit “burst effect,” (Figure 2A) as is observed in 
fluoride-releasing materials, such as glass ionomer cements, Fluor-I-Ties®, and Fluor-I-
Chain®. In contrast, our fluoride delivery system exhibits neither of these characteristics – 
it requires neither patient compliance nor exhibits “burst effect.” Moreover, our system 
differs from prior approaches in that it employs an overcoat technology whereby fluoride 
diffusion is controlled and constant therapeutic release is achieved (according to model in 
Figure 2B). 
 
1.3  Description of our Fluoride-releasing System 
 Our system reported herein involves the use of a polymer film as a fluoride-
releasing system. The chosen polymer is poly(ethylene-co-vinyl acetate) (PEVA) [Figure 
4], a biocompatible polymer suitable for various biomedical applications. It is the 
polymeric material of NUVA® estadiol-releasing vaginal rings, and it also exists as a 
copolymer [with poly(butyl methacrylate), PBMA] in the sirolimus-releasing coronary 
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stent, CYPHER™.24, 25 No adverse immune responses occur when it is placed inside the 
human body. Also, its mechanical 
properties are favorable for such 
applications. It is both tough and 
flexible, two properties that exist as 
the polymeric matrix consists of both 
crystalline and amorphous domains, the domains of ethylene and vinyl acetate 
respectively. Crystalline ethylene and amorphous vinyl acetate chains comprises the 
matrix of this semi-crystalline polymer. 
The construction of our fluoride-releasing device consists of two polymer layers: 
(1) an inner core and (2) an outer layer, which covers or “overcoats” the inner core 
(Figure 5). The inner core is loaded with powdered sodium fluoride granules. The outer 
layer is purely poly(ethylene-co-vinyl acetate), containing no sodium fluoride. In fact, 
this “overcoat” controls the diffusion rate of fluoride through the film. 
 
 
 
 
 
 
 
 
 
 
Figure 5. Construction of fluoride-releasing device. 
CH2 CH2 CH2 CH
O C
O
CH3
x y  
 
Figure 4. Poly(ethylene-co-vinyl acetate) (PEVA). 
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It is expected that the current system will translate to the development of 
fluoridated o-rings, which, when placed around orthodontic brackets, will release fluoride 
therapeutically for 4-6 weeks; thereafter, they will be replaced by an orthodontist during 
routine brace adjustments. 
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CHAPTER 2 Anatomy and Biochemistry 
 
 
2.1  Anatomy of Tooth 
The tooth comprises of two regions – the exposed, above the gum line, “crown” 
and the unexposed, “root,” which is concealed in the gums and embedded in the bone 
(Figure 6). The crown is covered by the enamel, the hardest tissue in the human body. 
The chemical structure of this highly mineralized substance is such that it can withstand 
the gigantic compressive forces during mastication (chewing), forces that range from 28 
N to greater than 1200 N.26 Adjacent to the enamel is the dentine, which comprises the 
 
 
Figure 6. Anatomy of tooth (cross-section). 
 
Source: The Visual Dictionary. http://www.infovisual.info/03/034_en.html 
(accessed August 7, 2009). Copyright 2005-2009 Bernard Dery. 
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majority of the tooth structure, encompassing both the crown and root. Compared to the 
enamel, the dentine is less mineralized, not as hard, and is more elastic. As a result, when 
forces are exerted on the enamel during mastication, the dentine “cushions” it, acting as a 
shock-absorber. That is, by dampening and distributing the forces during mastication, the 
dentine prevents the fracture of the enamel. The innermost structure of tooth is the pulp, 
composed of soft connective tissue containing blood vessels and nerves that extend from 
the crown and into the root and the bone; these nerves sense pain. Due to the presence of 
odontoblasts on its outer surface, the pulp provides cellular processes for renewal and 
repair for the adjacent dentine. Two important outer structures of the root are the 
cementum and the periodontal ligament (PDL), both of which collectively act to support 
the tooth in the bone. The cementum is chemically similar to bone and forms a thin layer 
on the tooth. The periodontal ligament is a group of connective fibers and is embedded in 
the bone. It attaches to the cementum and, as such, anchors the tooth structure in the 
bone. Moreover, the periodontal ligament contains pressure-sensitive receptors that are 
important in controlling the force of bite. When the force of bite becomes excessive, 
negative feedback is induced - these receptors (as well as those in the pulp) send signals 
to the brain to reduce the movement of jaws. 
The teeth are lodged in the upper and lower jaw bones - the maxilla and mandible 
respectively (Figure 7). The teeth-bearing area of the jaws is called the alveolar process 
(Figure 8). Contained in the alveolar process are tooth sockets, known as dental alveoli, 
that hold the roots of the teeth along with periodontal ligament. 
 11
 Each jaw can be seen as two halves, with each half housing a set of teeth. In each 
set, there are four types of teeth are present: incisors, cuspids (or canines), premolars, and 
molars (Figure 8). The arrangement of teeth in the two halves is symmetric to one 
another. 
In humans between the ages of 6 months and 2 years approximately, 20 temporary 
teeth - called primary or deciduous teeth - erupt.  Present in each half of the two jaws are 
a total 5 teeth with one of the following: central incisors, lateral incisors, cuspids, first 
molars, and second molars. These teeth are shed between 6 and 13 years of age and are 
replaced by 32 permanent adult teeth, i.e. there are 8 in each half, comprising one of: 
central incisors, lateral incisors, cuspids, first premolars, second premolars, first molars, 
second molars, and third molars. 
 
 
 
Figure 7. Maxilla and mandible. 
 
Source: Gray, H., Anatomy of the Human Body, 20 ed.; Lea & Febiger: 
Philadelphia, 1918. http://www.bartleby.com/107/242.html (accessed 
August 7, 2009). Copyright 2000 Bartleby.com, Inc. 
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2.2  Enamel Structure and Properties 
The teeth function in the first step of the digestion process, i.e. mastication. With 
the help of jaw movements, up-and-down and side-by-side, the teeth mechanically break 
down food in the mouth. When food is mechanically reduced to smaller pieces, the 
digestive process progresses effectively – the pieces are further reduced via digestive 
enzymes in the mouth and stomach. The various structures of the tooth collectively aid in 
the mechanical reduction of food; in particular, the highly mineralized outer structure of 
the crown, namely, the enamel, is crucial. The enamel possesses unique chemical and 
physical properties. Known as the toughest tissue in the human body, the enamel has a 
Knoop hardness number (KHN) of 343 ± 23 kg/mm2, which is close to that of mineral 
 
 
Figure 8. Left maxilla. 
 
 
Source: Gray, H., Anatomy of the Human Body, 20 ed.; Lea & Febiger: Philadelphia, 
1918. http://www.bartleby.com/107/38.html (accessed August 7, 2009). Copyright 2000 
Bartleby.com, Inc. 
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magnesia, MgO. The KHN of enamel is approximately 5-6 times greater than that of its 
adjacent structure, the dentine (KHN = 68 ± 3 kg/mm2).27 The less hardness, more elastic 
property of dentine explains its cushioning effect on the enamel during mastication. 
Acting as a shock-absorber, the dentine protects the enamel from fracture due to 
mastication forces. The enamel is a non-living substance, devoid of cellular processes for 
renewal and repair, unlike the dentine - which undergoes such processes due to the 
presence of odontoblasts on its inner surface in the pulp.  
The enamel derives its physical and chemical properties from its composition. 
The mature enamel is composed of three entities: 1) inorganic, apatitic calcium phosphate 
crystals; 2) organic, insoluble proteins; and 3) water. The inorganic crystals constitute the 
majority of the enamel structure, i.e. approximately 96 wt%, whereas the organic phase 
and water form about 0.1 wt% and 3.9 wt% respectively.28 The inorganic crystals are 
 
 
Figure 9. Apatite crystals in enamel. 
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shaped as long, thin rods or prisms and are arranged in a discontinuous pattern with small 
spaces between them (Figure 9). These spaces comprise the organic proteins and water. 
The enamel acquires its hardness from the high concentration of inorganic crystals in its 
composition, contrary to other mineralized tissues, which have significantly lower 
concentrations of inorganic crystals and higher organic content. For example, dentine and 
bone contain approximately 20% and 22 wt% of organics, whereas enamel possesses 
only about 0.1 wt%28. 
The inorganic portion of the enamel is primarily composed of calcium apatite 
crystals. The chemical model often used to describe the enamel is that of calcium 
hydroxyapatite [Ca10(PO4)6OH2]. The enamel may be referred to as an “impure” form of 
calcium hydroxyapatite. Obviously, pure calcium hydroxyapatite is composed of only 
three ionic species, namely, calcium, phosphate, and hydroxide ions. However, in the 
enamel apatite, other ionic species may replace calcium, phosphate, and hydroxide (Table 
1). Table 2 shows average concentrations of the major and minor constituents of enamel. 
Moreover, in addition to substitutions, there may be vacancies in the lattice. Considering 
both substitutions and vacancies, the stoichiometry of the enamel may be written as: 
[Ca8.9Na0.3Mg0.14K0.01V0.65] [(PO4)5.1(HPO4)0.4(CO3)0.5][(OH)1.08(CO3)0.05Cl0.1V0.77], where 
V = vacancy.29 
 
 
 
 
 
Table 1. Possible substitutions for calcium 
hydroxyapatite [Ca10(PO4)6OH2]. 
 
Ion Possible Substitutions
Ca2+ Na+, Mg2+, Sr2+ 
PO43− CO32−, HCO3−, HPO42− 
OH− F−, Cl−, CO3− 
 15
 
 
 
 
 
 
 
 
 
 
 
 
 
2.3  Enamel Demineralization 
Demineralization of the enamel involves the breakdown of the mineralized tooth 
structure as a result of acid attack. Demineralization begins with the destruction of the 
enamel and progresses with the deterioration of the dentine. In the advanced stage, with 
the outer calcified structures (the enamel and the dentine) damaged, the pulp becomes 
exposed. Enamel demineralization is essentially a medical condition, often referred to as 
dental caries. In the primary stage of dental caries, as acids attack the enamel surface, 
white spot lesions (WSLs) often appear on the tooth. Acid attack increases the porosity of 
the enamel structure. This increased porosity increases the scatter of light, resulting in the 
optical effect that gives WSLs their characteristic opaque appearance.  
The most widely accepted and the most basic theory explaining the dental caries 
mechanism is the one formulated by Miller in 1882, i.e. the chemicoparasitic theory, and 
Table 2. Constituents of sound human enamel. 
 
Constituent Concentration (wt%) 
Ca 33.6 – 39.4 
P 16.1 – 18.0 
CO3 1.95 – 3.66 
Na 0.25 – 0.90 
Mg 0.25 – 0.56 
Cl 0.19 – 0.30 
K 0.05 – 0.30 
 
Source: Adapted from Williams, R. A. D.; Elliot, J. C., 
Basic and Applied Dental Biochemistry; Churchill 
Livingstone: Edinburgh, 1989; p 345. 
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is concisely explained as follows. Acid formation is the result of fermentation reactions 
that occur in the mouth. Plaque, which is attached to tooth, contains several bacteria. 
These bacteria react with sugars to produce acids. In particular, streptococci are thought 
to be the prominent bacteria in caries formation. Low molecular weight sugars 
(monosaccharide and disaccharides) are involved in fermentation by bacteria, as opposed 
to high molecular weight sugars (polysaccharides). Monosaccharides (e.g. glucose and 
fructose) and disaccharides (e.g. sucrose) are easily fermented by bacteria. On the 
contrary, polysaccharides (e.g. starch) are not easily fermented by bacteria, as hydrolysis 
of these sugars is required before they can be consumed by bacteria. The major organic 
acid involved in the demineralization of enamel is lactic acid. The fermentation reaction 
involving the conversion of glucose to lactic acid by bacteria is shown in Figure 10. The 
hydrogen ions of acids react with the inorganic enamel apatite, resulting in its dissolution 
with the release of calcium and phosphate ions [EQ (1)]. 
 
 
 
 
 
 
 
 
                Ca10(PO4)6(OH)2 + 8H+ → 10Ca2+ + 6HPO42- +2H2O         ---------------EQ (1) 
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2.4  Anticariogenic Effect of Fluoride  
Fluoride may substitute the hydroxide (OH־) in the enamel apatite, resulting in the 
increased concentration of calcium fluoroapatite. Compared to calcium hydroxyapatite, 
calcium fluoroapatite is less soluble, a fact that may be explained by the better packing of 
crystals that occurs with fluoride ions. The crystals in hydroxyapatite contain hydroxide, 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10. Fermentation of glucose. 
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which are slightly bulkier than fluoride, and thus cannot pack as well as fluoroapatite 
crystals (Figure 11).30 Hence, fluoride ions may increase the concentration of the less 
soluble fluoroapatite in the enamel apatite, thereby reducing its acid solubility. 
   
 
 
 
 
 
 
 
Exposure to fluoride during the pre-eruptive stage of tooth development may 
shape the resistance of the mature enamel to caries attack. Fluoridation of drinking water 
has been shown to reduce the incidence of dental caries amongst children. Fluoride 
concentrations of less than 1 ppm show higher incidences of caries, whereas higher 
concentrations (> 1 ppm) result in another health concern, i.e. fluorosis.27 Caries 
resistance of the enamel depends on its composition and morphology. During the pre-
eruptive stage, the presence of adequate fluoride may produce an enamel apatite that is 
less soluble in acids. That is, the lower solubility of the enamel may be attributed to the 
increased concentration of fluoroapatite in its crystal lattice. This phenomenon is 
supported by the fact that children in higher fluoridated areas (1 ppm vs. 0.1 ppm) exhibit 
higher concentrations of fluoride in the surfaces of their enamel.27 
 
F
Ca
Ca
F
Ca
Ca
F
Ca
Ca
OH
Ca
Ca
OH
Ca
Ca
OH
Ca
Ca  
  
  
 
Figure 11. Arrangement of fluoride and hydroxide atoms with respect to calcium in 
fluoroapatite and hydroxyapatite crystals respectively (as viewed at right angles to the 
principle axis of the crystals). 
    Fluoroapatite (F in same plane as Ca)              Hydroxyapatite (bulky OH, which is not 
in same plane as Ca) 
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The anticariogenic effect of fluoride on mature enamel may be explained in terms 
of remineralization. Topical fluorides, e.g. toothpaste and mouth rinses, deliver fluoride 
to the enamel surfaces. On decalcified surfaces, the fluoride attracts calcium ions, 
resulting in calcification, i.e. remineralization takes place. The enamel undergoes, in a 
cyclic fashion, both demineralization and remineralization. The balance between the two 
processes determines the degree of demineralization. Fluoride therapy ensures that more 
remineralization (than demineralization) occurs. The net result, therefore, is that 
demineralization is inhibited and remineralization promoted. 
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CHAPTER 3 Calculations 
 
 
3.1  Calculation of Therapeutic Release Rates 
Laboratory and clinical studies suggest that demineralization may be inhibited if 
particular fluoride concentrations are maintained in saliva at all times.31, 32 An in vitro 
study indicated therapeutic concentrations of 0.024, 0.054, and 0.1 ppm F.32 The static 
fluoride concentrations (ppm F) may be translated to release rates (µg F/ring/day) using 
equation 2, which considers saliva physiology30, 33 (Table 3) and the number of rings (i.e. 
28). Hence, release rates (µg F/ring/day) are computed (Table 4). 
               
  
 
 
ringsofnumber
day1
min.1440
×
Fg1
Fµg10
×g/mLdensity,saliva×mL/minrate,swallowing×
salivag
Fg10
Fppmx
=F/ring/dayµg
66-  
           
              ---------------EQ (2) 
   
  where,  
  swallowing rate = 1 mL/min. (Table 1) 
  saliva density = 1 g/mL (Table 1) 
                          number of rings = 28 
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Therapeutic release rates may be presented as a range, having lower and upper 
limits, i.e. therapeutic and toxicity limits respectively. The release rate corresponding to 
0.024 ppm may be considered the lower limit, since this concentration is shown to be the 
minimum at which therapeutic effect or caries protection is achieved. On the other hand, 
the release rate corresponding to 1 ppm is set as the upper limit, as fluorosis occurs 
beyond this concentration. 
 
 
 
 
Table 4. Static fluoride concentrations 
and their corresponding release rates. 
 
Concentration 
(ppm) 
Corresponding 
Release Rate 
(µg/ring/day) 
0.024 1.2 
0.054 2.8 
0.1 5.1 
1 51.4 
Table 3. Properties of saliva. 
 
Property Value Units Reference 
Density 1 g/mL 30 
Volume of saliva in 
the mouth 1 mL 30 
Swallowing rate 1 mL/min. 33 
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3.2  Diffusion Mechanism 
The diffusion of fluoride through the polymer may be described by Fick’s 2nd 
Law (non-steady state diffusion) [EQ (3)]. Diffusion may occur in the radial and/or axial 
directions (Figure 12). However, according to scaling and dimensionless analysis (shown 
on the pages 23-24), axial diffusion dominates, i.e. diffusion in the radial direction may 
be neglected. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12. Axial (z-direction) vs. radial diffusion from the film; the 
former dominates. 
 23
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
Fick’s 2nd Law: 
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Introducing Dimensionless Variables: 
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where, Co = total fluoride concentration in the sample, to = total diffusion 
time, Ro = film radius, lo = film thickness 
 
Re-writing Fick’s 2nd Law [EQ (3)] in terms of dimensionless variables: 
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Multiplying L.H.S. and R.H.S. by
o
o
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Multiplying r-component and z-component by 2
o
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Since 
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t = (where ov is velocity), we have: 
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As Ro >> lo, radial diffusion may be neglected and thus z-component (axial) 
diffusion dominates. 
 
0 
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CHAPTER 4 Materials and Methods 
 
 
4.1  Materials and Equipment 
4.1.1  Films Preparation 
Poly(ethylene-co-vinyl acetate) (PEVA) [40 wt% vinyl acetate], in bead form, 
was purchased from Sigma-Aldrich. Tetrahydrofuran (THF) [Sigma-Aldrich] was the 
solvent used for PEVA dissolution. Powder sodium fluoride (ACS reagent, Sigma 
Aldrich) was the fluoride source of the films.  
To ensure homogeneity and particle break-up of powder sodium fluoride in the 
PEVA/THF solution, a vortex (VWR Scientific, Genie 2™) and an ultra-sonicator (VWR 
Scientific, Aquasonic™, Model 75HT) were employed. Dip-coated samples were dried 
using a vacuum oven (Napco®, Model 5831). A scanning electron microscope, ZEISS 
EVO® 50XVP (Carl Zeiss SMT, Inc., Peabody, MA), was used to image cross-sectional 
areas of samples.   
 
4.1.2 Release Studies 
Sodium fluoride solution (0.1M, Fisher Scientific) was used for prepare 
calibration samples for fluoride measurement. TISAB III (Total Ionic Strength 
Adjustment Buffer, Concentrate with CDTA, Thermo Fisher Scientific) was added to 
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release study solutions so that the background ionic strength is high and fluoride 
measurement inferences do not occur. Nanopure water from a filtration system 
(Barnstead Diamond™, Model D11961) was added to release study solutions. 
Fluoride measurements were taken using an ion meter (Corning, Model 450) and 
fluoride ion selective electrode (Corning, Model 476135). To maintain particular release 
study samples at 37°C, a water bath (VWR Scientific, Model 1235) was used.  
 
4.2  Experimental Procedure 
4.2.1  Preparation of Fluoride-impregnated Films 
Thin cylindrical films (diameter = 3.7 ± 0.5 inches; thickness = 0.024 ± 0.002 
inches) with four different fluoride 
contents/loadings (0.8, 2.5, 3.9, and 5.7 
wt% F) were prepared. The preparation of a 
particular wt% F film involved the 
following steps. First, a solution was 
prepared by dissolving 4.2 g of solid PEVA 
beads in 20 mL of tetrahydrofuran (THF). Corresponding to the desired wt% F film, the 
appropriate amount of sodium fluoride powder was added to the solution (Table 5); 
immediately upon addition, the solution was vortexed for 2 minutes, after which it was 
treated in a sonicator for 30 minutes. Immediately after sonication, the solution was 
poured into a Petri dish and was allowed to cast-dry for 3 days. During the drying 
Table 5. Amounts of NaF incorporated in 
PEVA/THF solution and corresponding 
wt% fluoride in formed films. 
 
Amount of 
NaF (g) Wt% F in Film 
0.08 0.8 
0.25 2.5 
0.4 3.9 
0.6 5.7 
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process, the solvent THF evaporated from the solution and a solid PEVA film (containing 
NaF) formed.  
 
4.2.2  Preparation of Uncoated, Single-coated, and Double-coated Samples 
Three circular samples (diameter = 1.3125 inches) were carved from each film 
prepared in the previous section (4.2.1); at that stage, the samples were uncoated. Coated 
samples required the following additional steps. Samples were dip-coated with PEVA 
solution (21% w/v PEVA/THF) contained in a beaker. The coated samples were dried in 
a vacuum oven for 24 hours. This produced a single-coated sample. To obtain double-
coated samples, the dip-coating procedure is repeated, i.e. the single-coated samples were 
dip-coated in the PEVA solution, thereafter vacuum dried for 24 hours. Dimensions for 
single-coated and double-coated samples are shown in Figure 11 and Table 6. 
Thickness measurements of samples were carried out with a digital micrometer. 
For each sample, at least three measurements were taken and their average was reported. 
To obtain overcoat thicknesses, measurements were recorded before and after coating. 
Cross-sectional areas of samples were imaged with SEM to visualize the layers 
(core and overcoat) and distribution of sodium fluoride. Prior to scanning, samples were 
immersed in liquid nitrogen and freeze-fractured so that the cross-sectional area is not 
transformed. SEM samples were gold-coated. Images were taken with an acceleration 
voltage of 15 kV. 
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4.2.3  Fluoride Release Measurements (Release Studies) 
A 50 mL buffer solution comprising of 45 mL nanopure water and 5 mL TISAB 
III (Concentrate with CDTA) was prepared in a 120 mL plastic container. A sample was 
immersed in the buffer and fluoride release from the film was measured using a fluoride 
ion selective electrode connected to an ion meter for a span of 30-45 days. Prior to 
measurements, the fluoride ion selective electrode was calibrated using solutions diluted 
from a 0.1M NaF standard solution.  
 
Table 6. Sample dimensions corresponding to Figure 13. 
 
Dimension Inches (″) Millimeters (mm) 
Diameter (d) 1.3125 33.3 
Entire thickness (l1) 0.391 ± 0.006 9.93 ± 0.15 
Core thickness (l2) 0.024 ± 0.002 0.62 ± 0.05 
Overcoat thickness (l3)   
Single-coated 0.007 ± 0.003 0.14 ± 0.03 
Double-coated 0.350 ± 0.003 0.27 ± 0.07 
 
 
Figure 13. Geometry of coated samples; dimension measurements are given in Table 6. 
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4.2.4  Summary of Experimental Samples and Conditions 
Release studies were conducted for the following: (1) uncoated samples at room 
temperature (20°C), (2) single-coated samples at room temperature (20°C), (3) uncoated 
samples at 37°C, (4) single-coated samples at 37°C, and (5) double-coated samples at 
37°C. An experimental outline is illustrated in Figure 14. Table 7 summarizes the sample 
and experimental parameters. 
 
 
 
 30
 
 
 
 
 
 
 
 
Figure 14. Experimental outline 
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Table 7. Summary of release study samples. 
 
Group 
Name 
Sample 
Size (n) 
Fluoride 
Loading  
(wt% F in 
sample) 
Number of 
Coatings 
Release Study 
Temperature 
(°C) 
P 3 0.8 0 20 
Q 3 2.5 0 20 
R 3 3.9 0 20 
T 3 5.7 0 20 
P 3 0.8 1 20 
Q 3 2.5 1 20 
R 3 3.9 1 20 
T 3 5.7 1 20 
P 3 0.8 0 37 
Q 3 2.5 0 37 
R 3 3.9 0 37 
T 3 5.7 0 37 
P 3 0.8 1 37 
Q 3 2.5 1 37 
R 3 3.9 1 37 
T 3 5.7 1 37 
P 3 0.8 2 37 
Q 3 2.5 2 37 
R 3 3.9 2 37 
T 3 5.7 2 37 
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CHAPTER 5 Results and Discussion 
 
 
Release studies are presented and analyzed in this chapter. The primary objective 
is to identify samples that exhibit therapeutic release over a span of 30-45 days. The 
release rates of therapeutic samples fall within the range of 1.2 to 51.4 µg F/ring/day. 
Optimal sample parameters (i.e. fluoride loading, overcoat thickness, and temperature) 
providing constant therapeutic release are noted.  
Since body temperature is 37°C, release studies at this temperature more closely 
mimic the mouth environment compared to those at room temperature (20°C). Hence, 
emphasis is given to the former studies, which are presented first. In the course of this 
work, room temperature studies were conducted prior to studies at 37°C. The justification 
for these studies is that, if therapeutic release is observed for a particular sample at room 
temperature, it may be extrapolated that the sample will also be therapeutic at 37°C. 
Room temperature studies are also important for comparison purposes with 37°C studies.  
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5.1  Release Studies at 37°C 
Uncoated samples exhibited the undesired “burst effect” for 1 day, after which 
further release ceased (Figure 15). Constant therapeutic release over the prescribed time 
period (30-45 days) was not achieved for these samples. On the other hand, with coated 
samples (both single-coated and double-coated), the “burst effect” was eliminated and 
controlled fluoride release was observed (Figures 16 and 17). Linear trends were fitted to 
the experimental data plotted on the cumulative release graphs. The slopes of these linear 
trends correspond to constant release rates. Table 8 gives the regression line equations 
and release rates of single-coated and double-coated samples.  
 
 
 
 
 
 
 
Figure 15. Cumulative release profiles of uncoated samples at 37°C. 
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Figure 16. Cumulative release profiles of single-coated samples (l3 ≈ 0.14 mm) at 37°C. 
 
Figure 17. Cumulative release profiles of double-coated samples (l3 ≈ 0.27 mm) at 37°C. 
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Table 8. Linear trend equations and average release rates of coated samples at 37°C. 
 
 
Sample Linear Regression Release Rates (corresponding to regression slopes) 
 
Group 
Fluoride 
Loading 
(wt% F 
Equation(s) R2 µg F/ring/day Duration (days) 
Within 
Therapeutic 
Range* 
P 0.8 y = (0.37)x + 1.2 0.967 0.37 0 – 45 no 
y = (3.13)x + 1.2 0.995 3.13 1 – 10 yes 
Q 2.5 
y = (0.80)x + 26.4 0.987 0.80 10 – 45 no 
y = (3.32)x + 0.6 0.998 3.32 1 – 14 yes 
R 3.9 
y = (1.25)x + 30.6 0.985 1.25 14 – 45 yes S
i
n
g
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e
-
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o
a
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e
d
 
(
l
3
 
≈
 
0
.
1
4
 
m
m
)
 
T 5.7 y = (1.75)x + 2.9 0.993 1.75 0 – 45 yes 
P 0.8 y = (0.16)x + 0.01 0.995 0.16 0 – 45 no 
Q 2.5 y = (0.76)x + 3.6 0.969 0.76 0 – 45 no 
R 3.9 y = (0.86)x + 3.6 0.984 0.86 0 – 45 no 
D
o
u
b
l
e
-
c
o
a
t
e
d
 
(
l
3
 
≈
 
0
.
2
7
 
m
m
)
 
T 5.7 y = (1.78)x + 1.7 0.993 1.78 0 – 45 yes 
 
* It is indicated whether release rates were within the therapeutic range of 1.2 ≤ µg F/ring/day ≤ 51.4 (yes or no).  
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Of the four groups of single-coated samples, two groups, namely R (3.9 wt% F) 
and T (5.7 wt% F), displayed therapeutic release for 45 days. Group Q (2.5 wt% F) was 
observed to be therapeutic for only 10 days, whereas group P (0.8 wt% F) did not reach 
therapeutic limits at all. The release profile of group R consists of two constant release 
regions, rather than one (Figure 18 and Table 8). The first region, i.e. from day 0 to day 
15, shows therapeutic release at a rate of 3.32 µg F/ring/day. This rate decreases 
thereafter (beyond 15 days) to 1.25 F/ring/day, but is still within therapeutic range (1.2 ≤ 
µg F/ring/day ≤ 51.4). Group T has one constant release region showing a rate of 1.75 µg 
F/ring/day (Figure 19 and Table 8).  
 
 
 
 
Figure 18. Cumulative release of single-coated group R (3.9 wt% F) at 37°C. 
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An unexpected behavior was observed for group T. With the highest fluoride 
loading amongst the groups, group T (5.9 wt% F) was expected to release fluoride at the 
highest rate, at least for one week approximately. That is, for a minimum of one week, 
the release profile was expected to be located above that of group R (3.9 wt% F) in the 
cumulative graph (Figure 16). Rather, its profile is located below that of two lower 
fluoride content groups, Q (2.5 wt% F) and R (3.9 wt% F) for approximately 22 days, 
after which, it falls between these two groups. Given the behavior exhibited by group T, 
it would be of interest to investigate the release characteristics of samples loaded beyond 
5.7 wt% F (group T loading). 
 
 
 
 
 
Figure 19. Cumulative release of single-coated group T (5.7 wt% F) at 37°C. 
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5.1.1  Effect of Overcoat Thickness on Coated Samples 
 For a particular group, the transition from single-coated to double-coated was 
expected yield significantly less release rates. As observed from Table 9, this expectation 
was fulfilled by the following groups at particular release regions: 1) P [45 days], 2) Q 
[region 1, i.e. 0 - 10 days], 3) R [region 1, i.e. 0 - 14 days]. Single-coated and double-
coated release profiles of group R are shown in Figure 20. Group T deviated from the 
expected outcome, i.e., with the transition, no change in release rate occurred. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
Table 9. Effect of sample overcoat thickness on release rates at 37°C. 
 
Sample Release Rate              (µg F/ring/day) 
Group 
Fluoride 
Loading 
(wt% F) 
Single-
coated 
(l3 ≈ 0.14 mm) 
Double-
coated 
(l3 ≈ 0.27 mm) 
Decrease in 
Release Rate 
(ratecolumn 3 / 
ratecolumn 4) 
P 0.8 0.37 0.16 2.3 
3.13 4.1 
Q 2.5 
0.80 
0.76 
1.0 
3.32 3.8 
R 3.9 
1.25 
0.86 
1.4 
T 5.7 1.75 1.78 1.0 
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Calculations have shown that diffusion of fluoride through the film primarily 
occurs axially, rather than radially (Section 3.2, Figure 12). Due to this, the overcoat 
layer becomes a barrier for molecules diffusing in the axial direction. Therefore, 
controlled fluoride diffusion may be achieved by adjusting overcoat thickness. In the 
release studies, two overcoat thicknesses were tested: 0.14 and 0.27 mm (approximately), 
corresponding to single-coated and double-coated samples respectively. Increasing the 
overcoat thickness provided better control for groups Q and R. As single-coated samples, 
both groups exhibited two regions of release in their respective cumulative graphs (Figure 
16). The first region is characterized by high release, as seen by the steep slope. With the 
end of this region, there is a significant decline in release thereafter, denoted as the 
second region, the slope of which is much less. However, double-coated samples released 
 
Figure 20. Single-coated and double-coated group R (3.9 wt% F) at 37°C: 
l3 ≈ 0.14 and 0.27 mm, respectively. 
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fluoride at a single rate over the time span (Figure 17 and Table 8). A single release 
region, as opposed two regions, signifies better control. 
 The idea of better control may be understood by considering the boundary and 
initial conditions governing the diffusion mechanism through the overcoat. A single 
constant release rate occurs if the inner surface of the overcoat (adjacent to the core) is 
kept at a constant concentration for any time, t > 0. That is, constant activity 
(concentration) throughout the release period is maintained at the surface of the reservoir 
(core), adjacent to the inner surface of the overcoat. This case possibly holds true for all 
the double-coated samples. The overcoat thickness maintained release such that the 
concentration of fluoride in the core was always high enough to provide a constant 
activity at the inner surface of the overcoat. Therefore, a single constant release rate was 
observed for these samples. In contrast, the single-coated Q and R are characterized by a 
faster constant release region followed by a slower constant release region. By the end of 
the first region, the fluoride concentration in the core is depleted enough that constant 
activity can no longer be maintained at the inner surface of the overcoat. This non-
constant activity causes the decline in release rate. 
 The rate of fluoride depletion in the core affects overall release through the film. 
To gain a qualitative idea of the depletion rate, the percent of the total fluoride content 
(mass) depleted during the release regions were calculated (Table 10). For single-coated 
groups Q and R, 37% and 35% are depleted in the first regions respectively. These 
percentages may be reasonably high enough to justify the non-activity that results in the 
second region. In the case of double-coated Q and R samples, less fluoride is depleted at 
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the end of the time durations corresponding to the first regions of the single-coated 
samples, i.e. durations of 10 and 14 days, during which they release 26% and 28% 
respectively.  
At the end of the 45-day period, single-coated groups Q and R released 69% and 
64% of the fluoride content, respectively. From double-coated Q and R, less is depleted, 
i.e. 60% and 57% respectively (region 2). Their lower percentages during the first and 
second regions may imply that constant activity is maintained at the inner surface of the 
overcoat. The thicker overcoat of the double-coated samples did not allow for a faster 
depletion of fluoride concentration in the core compared to single-coated samples. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 10. Average percent of fluoride content released from single-coated and double-coated 
samples at 37°C. 
 
 Sample Release Rates  
 Group wt % F µg F/ring/day Duration (days) 
% Fluoride 
Content 
Released 
P 0.8 0.37 0 – 45 57 
3.13 1 – 10 37 
Q 2.5 
0.80 10 – 45 69 
3.32 1 – 14 35 
R 5.7 
1.25 14 – 45 64 S
in
gl
e-
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at
ed
 
(l 3
 ≈
 0
.1
4 
m
m
) 
T 3.9 1.75 0 – 45 40 
P 0.8 0.16 0 – 45 31 
Q 2.5 0.76 0 – 45 60 
R 5.7 0.86 0 – 45 57 
D
ou
bl
e-
co
at
ed
 
(l 3
 ≈
 0
.2
7 
m
m
) 
T 3.9 1.78 0 – 45 46 
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The existence of two-region release profiles of single-coated Q and R may be 
explained by considering the distribution of fluoride in the core. SEM images seem to 
reveal that fluoride is not homogeneously distributed in the core, but rather is 
concentrated near-surface (Figure 21 on the next page). If the fluoride molecules were 
evenly distributed along the axial length of the core, they would have experienced longer 
diffusion paths within the polymer matrix, and release would have been slower. With 
fluoride concentrated near-surface, the diffusion paths are shorter, and hence, release 
occurs at a faster rate.  
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(A) 
 
 
(B) 
 
Figure 21. SEM imaging of sample cross-sections. (A) Single-coated sample 
R (3.9 wt% F). The core and overcoat layers are distinguishable. 
(B) Uncoated sample T (5.7 wt% F). Located near-surface, the rugged 
formations are due to fluoride presence. 
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5.2  Release Studies at Room Temperature (20°C) 
Like 37°C studies, “burst” profiles were also obtained for uncoated samples at 
room temperature (Figure 22). Unlike 37°C studies, groups P and Q showed longer burst 
release periods (3 days compared to 1 day). For groups R and T, the burst effect 
diminished within one day. In contrast, single-coated samples yielded constant releases. 
The magnitude of release increased with increasing fluoride content in the groups (Figure 
23). Three groups (Q, R, and T) exhibited two release regions; group P had one. 
However, it is important to note that these studies did not demonstrate therapeutic 
releases (Table 11) for 30-45 days. Considering the percent fluoride depletion during 45 
days, comparisons may be drawn with coated samples at 37°C. For a given group, the 
depletion was comparatively less at room temperature, with the exception of group T 
(single-coated) [Table 12]. Moreover, worth mentioning is the fact that same depletion 
value (46%) was obtained for: (1) single-coated group T at room temperature and (2) 
double-coated group T at 37°C. 
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Figure 22. Cumulative release profiles of uncoated at room temperature (20°C). 
 
Figure 23. Cumulative release profiles of single-coated samples (l3 ≈ 0.14 mm) at room 
temperature (20°C). 
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Table 11. Linear trend equations and average release rates of single-coated samples at room temperature (20°C).  
 
Sample Linear Regression Release Rates (corresponding to regression slopes) 
Group 
Fluoride 
Loading 
(wt% F)
Equation(s) R2 µg F/ring/day Duration (days) 
Within 
Therapeutic 
Range* 
P 0.8 y = (0.21)x + 0.3 0.990 0.21 0 – 45 no 
y = (1.76)x + 0.2 0.994 1.76 1 – 9 yes 
Q 2.5 
y = (0.59)x + 11.0 0.982 0.59 9 – 45 no 
y = (1.81)x + 6.7 0.933 1.81 1 – 20 yes 
R 3.9 
y = (0.65)x + 26.8 0.969 0.65 20 – 45 no 
y = (3.43)x + 6.7 0.951 3.43 1 – 17 yes 
T 5.7 
y = (1.19)x + 41.2 0.980 1.19 17 – 45 no 
 
* It is indicated whether release rates were within the therapeutic range of 1.2 ≤ µg F/ring/day ≤ 51.4 (yes or no).  
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Table 12. Average percent of fluoride content released after 45 days from 
coated samples at room temperature (20°C) compared to that at 37°C. 
 
 Sample % Fluoride Released 
 Group wt % F RT (20°C) 37°C 
P 0.8 34 57 
Q 2.5 42 69 
R 5.7 40 64 
Si
ng
le
-c
oa
te
d 
(l 3
 ≈
 0
.1
4 
m
m
) 
T 3.9 46 40 
P 0.8 - 31 
Q 2.5 - 60 
R 5.7 - 57 
D
ou
bl
e-
co
at
ed
 
(l 3
 ≈
 0
.2
7 
m
m
) 
T 3.9 - 46 
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CHAPTER 6 Conclusions 
 
 
Table 13 summarizes the results obtained for coated samples at 37°C. Of the 
single-coated samples, groups R (3.9 wt% F) and T (5.7 wt% F) showed therapeutic 
release. Amongst double-coated samples, only group T (5.7 wt% F) was therapeutic. The 
magnitudes of standard deviations for the average release rates seem justified, 
considering that diffusion occurred through a semi-crystalline polymer, within which the 
presence of crystalline domains may have complicated diffusion. Attention is required to 
the question of whether the therapeutic samples will translate to efficacious o-rings, 
capable of inhibiting demineralization in a patient’s mouth. From the results of this study, 
it may be inferred that o-rings, developed from the therapeutic samples, will perform 
favorably in vivo. Although the release rates of the samples are towards the lower end of 
the therapeutic range (1.2 ≤ µg F/ring/day ≤ 51.4), they are expected to increase in vivo. 
With the effect of convection (saliva flow) in the mouth, the release rates should be 
higher. This fact is supported by studies that compared in vivo release of fluoride from 
fluoridated o-rings to in vitro. In an in vivo setting, the release was shown to be 
significantly higher.22, 34 With regard to our samples, increased release rates could mean 
that the fluoride contents will be exhausted before the prescribed duration of 30-45 days, 
i.e. therapeutic releases cannot be sustained. However, results suggest that it is unlikely 
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that the fluoride contents will be exhausted before 45 days. Let us consider the case of 
therapeutic single-coated group T at 37°C. At the end of 45 days, only 40% of the 
fluoride content is depleted (Table 13), i.e. 60% is still available for release. Despite 
presumably releasing at higher rates in vivo, the o-rings developed from our samples may 
still possess the capacity to sustain therapeutic rates - the fluoride contents are not 
expected to be exhausted before 45 days. 
Future work involves conducting further release studies at 37°C for: (1) single-
coated samples with different fluoride loadings in the range of 3.9 wt% to 5.7 wt%, (2) 
single-coated samples with fluoride loadings beyond 5.7 wt%, and (3) double-coated 
samples with fluoride loadings beyond 5.7 wt%. In addition, mechanical stress testing of 
the samples should be conducted. 
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Table 13. Summary for single-coated and double-coated samples at 37°C. 
 
 Sample Release Data   
 Group 
Fluoride 
Loading 
(wt% F) 
Average      
µg F/ring/day 
(n = 3) 
Relative 
S.D. (%) 
Duration 
(days) 
% Fluoride 
Content 
Released 
Static F 
Concentration 
(ppm)Ψ 
Within 
Therapeutic 
RangeΦ 
P 0.8 0.37 39 0 – 45 57 0.007 no 
3.13 32 1 – 10 37 0.061 yes 
Q 2.5 
0.80 31 10 – 45 69 0.015 no 
3.32 33 1 – 14 35 0.065 yes 
R* 3.9 
1.25 10 14 – 45 64 0.024 yes S
i
n
g
l
e
-
c
o
a
t
e
d
 
(
l
3
 
≈
 
0
.
1
4
 
m
m
)
 
T* 5.7 1.75 26 0 – 45 40 0.034 yes 
P 0.8 0.16 48 0 – 45 31 0.003 no 
Q 2.5 0.76 14 0 – 45 60 0.015 no 
R 3.9 0.86 44 0 – 45 57 0.017 no 
D
o
u
b
l
e
-
c
o
a
t
e
d
 
(
l
3
 
≈
 
0
.
2
7
 
m
m
)
 
T* 5.7 1.78 16 0 – 45 46 0.035 yes 
 
* Samples that showed therapeutic rates for 45 days. 
Ψ Corresponds to static fluoride concentration in the mouth; values were obtained by solving for x (ppm) in equation 2.    
Φ It is indicated whether release rates were within the therapeutic range of 1.2 ≤ µg F/ring/day ≤ 51.4 (yes or no).  
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